[1]
“EVALUATION OF PRESCRIPTION PATTERN AND ASSOCIATED DRUG INTERACTIONS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH COMORBIDITIES AND COMPLICATIONS IN A TEACHING CARE HOSPITAL”, Int. Res. J. Pharm., vol. 7, no. 5, pp. 43–47, May 2016, Accessed: Nov. 03, 2026. [Online]. Available: https://irjponline.org/index.php/irjp/article/view/1319